ART4 and severe acute respiratory syndrome: In this study we used a panel of these recombinant SARS-CoV bearing variant S glycoproteins to develop new models of SARS-CoV infection in non-human primates that could be used to test vaccine candidates and therapeutics against heterologous challenge.